The U.S. Food and Drug Administration has approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of m...
Eisai has announced that the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and...
China based BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innova...
US based Turnstone Biologics, a biotechnology company pioneering the development of engineered viral immunotherapies,&nb...
Roche has announced that the European Commission has approved Kadcyla® (trastuzumab emtansine) for the adjuvant (aft...
Pfizer and Japan based Astellas Pharma have announced that the U.S. Food and Drug Administration (FDA) has approved a su...
AstraZeneca and Daiichi Sankyo Company presented positive detailed data from the global pivotal Phase II single-arm DEST...
Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in Chi...
Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Ty...
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 R...
Astellas Pharma Inc., based in Tokyo, Japan has announced the China National Medical Products Administration ...
Pfizer Inc. on 25th Nov 2019, announced the efficacy and tolerability results from the subgroup analysis of Asian patien...
Merck, a leading science and technology company, on 25 Nov 2019, announced the presentation of multiple abstracts on tep...
BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...
South Korean healthcare company, Yuhan Pharmaceuticals (Yuhan) and Cyclica Inc. (Cyclica), a leading neo biotechnology c...
The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing o...
South Korea headquartered Samsung Biologics has announced the signing of a long-term agreement with US based Ichnos Scie...
Merck and Pfizer Inc. on 29 Oct 2019, announced that the European Commission (EC) has approved BAVENCIO® (avelu...
